WHWK
Whitehawk Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$199.69M
P/E Ratio
—
EPS
$-0.33
Beta
0.62
52W High
$4.48
52W Low
$1.53
50-Day MA
$3.65
200-Day MA
$2.58
Dividend Yield
—
Profit Margin
-288.30%
Forward P/E
2.66
PEG Ratio
—
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. The company is headquartered in Morristown, New Jersey.
Fundamentals
| Revenue (TTM) | $7.14M |
| Gross Profit (TTM) | $-84.58M |
| EBITDA | $-114.32M |
| Operating Margin | -1601.00% |
| Return on Equity | -21.80% |
| Return on Assets | -64.70% |
| Revenue/Share (TTM) | $0.12 |
| Book Value | $2.89 |
| Price-to-Book | 1.47 |
| Price-to-Sales (TTM) | 27.95 |
| EV/Revenue | 7.59 |
| EV/EBITDA | -0.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $49.43M |
| Float | $17.88M |
| % Insiders | 13.75% |
| % Institutions | 72.52% |
Historical Volatility
HV 10-Day
55.87%
HV 20-Day
69.43%
HV 30-Day
73.29%
HV 60-Day
68.89%
HV Rank
70.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.25 target)
2
Buy3
HoldData last updated: 4/30/2026